On the other hand, multiple lines of evidence suggest that AMP-activated protein kinase (AMPK) phosphorylation is reduced in early stages of diabetic cardiomyopathy [42], whereas extracellular signal-regulated kinase (Erk1/2)/TGF-β signaling pathway is activated. This evidence concerns the gene MAPK3 and diabetic cardiomyopathy.